Advanced Filters
noise

A, Almada N Clinical Trials

A listing of A, Almada N clinical trials actively recruiting patients volunteers.

Found 11,120 clinical trials
P Philippe Nadeau, Ph.D.

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

Bispecific antibody therapies targeting BCMA (B-cell maturation antigen) represent a novel therapeutic approach for patients with multiple myeloma. They are currently used in cases of refractory multiple myeloma but are also being investigated in earlier lines of treatment. However, these new therapies can lead to deeper immunosuppression and exacerbate an …

18 years of age All Phase 4

A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)

The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.

18 - 60 years of age All Phase 1
E Erin Loweree

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.

22 - 100 years of age All Phase 4
M Meray M Shokry Zaghary

A Comparative Study of Using Scorpion Antivenom Versus Scorpion Antivenom and Prazosin

Interventional study designed for the evaluation of characters and the outcome of scorpion sting patients will admit to Sohag University Hospitals in 2 randomized groups. The first group will receive scorpion antivenom only whether by the intravenous or the intramuscular route of administration. The second group will receive a combination …

1 - 70 years of age All Phase 4

A Study of T-DXd in Patients With Selected HER2-overexpressing Tumors

This is an open-label, multicenter, Phase II study to evaluate the efficacy and safety of trastuzumab deruxtecan for the treatment in locally advanced, unresectable, or metastatic patients with selected HER2 overexpressingsolid tumors which are not eligible for curative therapy.

18 - 130 years of age All Phase 2

The Trial of a New Infant Formula in Healthy Term Chinese Infants

The aim of this randomized, controlled, multi-center, double-blind study of healthy term infants is to test the safety and efficacy of a new infant formula with a specific blend of six human milk oligosaccharides. The primary objective of the trial is to demonstrate the safety of the new infant formula …

- 14 years of age All Phase N/A
B Brent Mausbach, PhD

A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers

This is a randomized controlled trial over 5 years, using Stage II of the NIH-defined stage model for behavioral intervention development. We will evaluate the efficacy of the sleep intervention program (Care2Sleep) on sleep, health status measures, and quality of life (for dyads), and inflammation (for caregivers only). Eligible participants …

18 years of age All Phase N/A
S Svetlana Azova, MD

Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard Diet

Despite major technological advances, management of type one diabetes mellitus (T1D) remains suboptimal, putting millions of people at risk for immediate and long-term complications. After meals, a mismatch between carbohydrate absorption rate and insulin action typically leads to alternating periods of hyper- and hypoglycemia. A conceptually promising approach to control …

18 - 40 years of age All Phase N/A
Q Qiubai Li, Professor

Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis

The primary objective of the study was to evaluate the safety and tolerability of A-319 in patients with active rheumatoid arthritis.

18 - 70 years of age All Phase 0
A Armin Zlomuzica, PhD

Self-efficacy Enhancement in a Virtual Reality Training for Fear of Heights

Self-efficacy (SE) enhancement after virtual reality exposure (VRET) for heights can promote treatment-induced effects (Raeder et al. 2019). Raeder et al (2019) employed an intervention to enhance SE by introducing specific questions about autobiographical events of success and mastery experiences in the course of VRET. Building on these previous findings, …

18 - 65 years of age All Phase N/A

Simplify language using AI